Other Stories

Full Video

S. Korea approves Celltrion's antibody COVID-19 treatment Updated: 2021-09-17 18:19:29 KST

South Korea's drug safety ministry has given official approval to the antibody COVID-19 treatment developed by the local pharmaceutical company Celltrion.
The treatment is called Rekirona.
It's the country's first locally made antibody treament, and it's for severely-ill COVID-19 patients aged over 50.
Celltrion submitted the results of the global phase of the third clinical trial last month.
It now plans to accelerate its efforts to get full authorization in other countries.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.